Santorini Scientific extend partnerships with internship at Imperial
25 May 2022
Exploring TReg therapy to reduce post-transplant rejection
This summer, Santorini Scientific will be co-funding an internship with Imperial College London on Regulatory T-cell (TReg) therapy.
As the name suggests, TRegs are responsible for regulating immune responses therefore can be used to reduce autoimmune responses such as in cancer or, theoretically, rejection following a heart transplant.
Remodelling of the infarcted heart: piezoelectric multifunctional patch video release
Santorini Scientific Ltd and UWE Bristol announce new Accelerated Knowledge Transfer (AKT): Accelerating development of a multi-sensor, multi-culture cell model for evaluation of heart transplant rejection to enable personalised treatment
After a competitive process, project funding has been awarded by Innovate UK to Santorini Scientific for modelling rejection as a platform for future post-transplant therapies
Developing a model for analysing heart transplant patient data
SSL secured AHSN Network Grant in Collaboration with the University of The West of England
Santorini Scientific is participating in a European scientific study funded by Horizon Europe to help the 2 million people in Europe affected by heart disease every year
Non-invasive Diagnostics will reduce patients’ stress factors and infection risks
SSL is looking to purchase a 3D Bioprinter and technical support. Can you help? If so, please download and reply to our tender.
27 June 2022: ERDF funding under the KEEP+ programme to work with UWE
17 May 2022: Post Graduate Taught (PGT) Knowledge Exchange Pathway (KEP)